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Abstract
The use and abuse of inhalants continue to be among the most pernicious, curious, and least understood of drug use behaviors. The
purpose of this study was to identify specific subgroups of adolescents based on their reasons for using inhalants. Data regarding reasons for
using inhalants were examined using latent profile analysis. A three-class solution exhibited the best fit with the data. Although validation
analysis revealed that the classes did not differ on demographic characteristics, classes exhibited significant differences across numerous
clinical measures, including anxiety, problems associated with using substances, global symptom severity, and number of different types of
inhalants used. Results indicate heterogeneity for reasons for use of inhalants and associated psychological distress. Findings may provide
clues to future taxonomic development of inhalant abuse phenomena and prevention. D 2008 Elsevier Inc. All rights reserved.
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1. Introduction
Studies indicate that an estimated 9% to 20% of
adolescents have engaged in bhuffingQ or bsniffingQ of
inhalants such as gasoline, glue, shoe polish, paint, and
correction fluid (Garofalo, Wolf, Wissow, Woods, & Good-
man, 1999; Johnston, O’Malley, Bachman, & Schulenberg,
2006; Wu, Pilowsky, & Schlenger, 2004). Effects are rapid
and include slurred speech, ataxia, and other symptoms that
are similar to alcohol intoxication (Rosenberg & Sharp,
1997). The inhaling of volatile organic compounds con-
tained within these widely available household products
among adolescents remains poorly understood. Although
there is speculation on why people use inhalants, to our
knowledge, there has not been any systematic study of the
reasons for inhalant use. Brouette and Anton (2001) also
argue that, while the rate of inhalant abuse continues to rise,
it is still one of the least studied or discussed groups of
abused substances. This is unfortunate because knowledge
of the reasons for using inhalants may eventually lend
itself to the development of targeted prevention and
treatment strategies. Different reasons for use may also
shed light on the types of youth who abuse inhalants and
their associated levels of psychopathology. If there is
heterogeneity in reasons for use that are distinctly associated
with various indicators of internalizing and externalizing
behaviors, then this knowledge not only can stimulate future
taxonomic research on inhalant use but also can focus
treatment resources.
The purpose of this study was to explore the existence of
relatively discrete classes of youth based on reasons for
using inhalants by employing latent profile analysis (LPA).
Classes identified were then compared across measures of
psychological distress, externalizing behaviors, and fre-
quency of inhalant use. As this is the first study to utilize
latent variable modeling to uncover homogeneous sub-
groups of adolescent inhalant users, we had no a priori
taxonomy from which to derive classes. Thus, no hypoth-
eses are offered.
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2. Materials and methods
2.1. Sample and procedures
The present study sample (N = 277) of inhalant users was
drawn from a larger survey of the population of current
residents (N = 740) in the Missouri Division of Youth
Services (DYS). Participation in the study was voluntary.
The Missouri DYS is the legal guardian of all residents who
are committed to its care by the state’s 45 juvenile courts.
Face-to-face interviews of all youth were conducted using a
comprehensive solvent assessment inventory. All inter-
viewers completed an intensive 1-day training session, and
an interview editor was on-site at each facility as youth were
interviewed to minimize interviewer omissions and errors.
DYS residents are under 24-hour-a-day supervision; thus,
interviews were conducted in large rooms that provided
private areas where confidential interviews could be
conducted simultaneously with between three and six youth.
The sample recruitment protocol ensured that no youths
who had completed the interview at one facility attempted to
complete or were successful in completing the interview at
another facility. This study was approved by DYS, the
Washington University Human Studies Committee Institu-
tional Review Board, and the federal Office of Human
Research Protection and was granted a Certificate of
Confidentiality by the National Institute on Drug Abuse.
Youth received US$10.00 for their participation.
All youth providing written informed consent completed
the structured, face-to-face, approximately 45-minute inter-
view assessing demographic characteristics, lifetime and
annual use of inhalants, other drug use, substance-related
problems, current and lifetime psychiatric symptoms, and
externalizing behaviors.
2.2. Survey
A set of 15 survey items reflecting a broad range of
reasons for using inhalants was included in the survey.
These items were adapted from the Reasons for Drinking
Questionnaire (RFDQ; Zywiak, Connors, Maiso, &
Westerberg, 1996). Subjects responded to the survey
items by indicating their level of agreement for use based
on a 5-point Likert-type response scale (1 = strongly
disagree, 5 = strongly agree). These survey items
exhibited good face validity with respect to inhalant
use. The internal consistency of the items was a = .82.
Because this is a new measure, no additional information
about its psychometric properties is available.
2.3. Analytic strategy
2.3.1. Latent profile analysis
As previously stated, LPAwas used to identify subgroups
of subjects who provided qualitatively different sets of
reasons for using inhalants. LPA is similar to latent class
analysis (LCA), except that LPA uses continuous observed
measures whereas LCA analyzes dichotomous measures.
The underlying assumption of LPA is that the relationship
among continuous indicators can be explained by a
categorical latent variable. The continuous indicators are
considered to be locally independent, meaning that the
observed items are statistically independent within each
latent class (Lazarfeld & Henry, 1968; Ruscio, 2004).
LPA was carried out using Mplus (version 4.2) in an
exploratory fashion. Specifically, rather than testing a class
solution specified a priori, the fit of a series of different
models was examined. A single-class model was examined
first, and classes were added until no further improvements
were observed. The empirical fit of the model was based on
the Bayesian Information Criterion (BIC). An improvement
in model fit results in a lower value on the BIC. Entropy was
also examined, which is an index reflecting how well the
indicators predict class membership. Values closer to 1.0
indicate better prediction.
Because there are a number of models that can exhibit a
good fit with the data, the conceptual fit of the model was
also considered in the analysis. This involved examining the
overall results and diagnostics of the model and using visual
representations of class profiles to assess the interpretability
and practical implications of class solutions.
2.3.2. Validation analysis
A validation analysis of the final model was conducted
by testing associations of class characteristics with demo-
graphic and clinical measures. This analysis was carried
out using SPSS (version 14.0). Measures were selected
based on prior empirical associations with substance use
among adolescents.
Specific demographic measures included age (in years),
gender (male/female), and receipt of public assistance (yes/
no). Because DYS system youth are predominantly African
American and White, race was measured by collapsing
categories to create a dichotomous measure (White/non-
White). Location of residence prior to commitment was
measured with four categories: urban city, suburban area,
small town, and rural area.
A set of clinical measures was selected for the validation
analysis. These included four measures from the Brief
Symptom Index (BSI), namely, depression, anxiety, para-
noid ideation, and psychoticism, and the overall global
severity sum score (a = .96). Prior experiences of suicide
ideation and substance use problems were assessed using the
Massachusetts Youth Screening Inventory (i.e., MAYSI-2).
These subscales consist of yes/no items. The total number
of affirmative item responses was then summed to provide
an overall scale score. Studies using the MAYSI-2 in
incarcerated youth samples have found it to be reliable
(Grisso, Barnum, Fletcher, Cauffman, & Peuschold, 2001).
Polysubstance use was derived from a composite of self-
reported use episodes of 14 types of substances. A measure
of externalizing behaviors was derived from the Self-Report
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of Delinquency (a = .84), which asks youth if they have
been involved in various forms of nonviolent and violent
antisocial acts in the past 12 months. From a set of 65
different types of inhalants, subjects were also queried about
the different types of inhalants they used over their lifetime.
It should be noted that higher scores on the clinical




Approximately 75% of the sample (n = 209) was
White, and 84% (n = 233) were male. The mean age was
15.6 years (SD = 1.12). Thirty-nine percent (n = 107)
reported that their family received public assistance. We
examined differences between inhalant users and non-
inhalant users using chi-square and t tests. No differences
were observed with respect to age, gender, and family
receipt of public assistance. However, inhalant use was
associated with urbanicity, v2(1) = 53.72, p b .001, with
a greater proportion of inhalants living in small towns/
urban areas. Inhalant use was also more common among
White subjects versus non-White subjects, v2(1) = 131.83,
p b .001.
3.2. Descriptive summary
Table 1 summarizes the reasons, ordered by the highest
mean value of agreement. Curiosity about the effects of
inhalants was the most common reason for using inhalants,
followed by feelings of boredom and that they are easier to
get than other drugs. Liking inhalants more than other drugs
was the least common answer. Feeling angry with someone
else, angry with self, and family problems also had low
mean values.
3.3. Latent profile analysis
A total of five LPA models were examined, ranging from
one to five classes. Each model was estimated with 200
random starts, and no problems with local maxima were
observed. The empirical fit of the models and their
estimated class sizes are summarized in Table 2. The one-
class solution exhibited a poor fit with the data relative to
the other models. A decrease in the BIC was observed with
the subsequent models, with the exception of the five-class
solution, which showed a slight increase relative to the four-
class solution. The entropy values for all the models were
very similar and greater than .90, indicating that the reasons
for using inhalants were strong predictors of class member-
ship. However, the differences in entropy values across the
different solutions were not considered to have any practical
significance. Overall, the four-class solution exhibited the
best empirical fit with the data based on the BIC. However,
the improvement from the three-class to four-class solution
was very small.
The conceptual fit of the models was examined through
visual inspection. This involved plotting the estimated mean
values for each reason by each class. The four-class solution
was examined first. Although each class of this model was
clearly distinguishable, Classes 2 and 3 had mean values
that were nearly identical for 8 of the 15 reasons. For the
seven reasons that showed noticeable differences, Class 3
exhibited higher values. The differences in these two classes
did not appear to have practical significance.
The profiles of the three-class solution were clearly
distinguished (see Fig. 1). There was also greater variability
in mean values on the reasons compared to the four-class
solution. The class sizes were also fairly balanced (see
Table 2). Class 1 had the lowest mean agreement values for
all the reasons. Although the overall fit of the three-class
solution was slightly lower than that of the four-class
solution based on the BIC, this model was considered to
have greater conceptual fit and practical implications. Thus,
the three-class solution was retained as the final model.
Table 1
Summary of reasons for using inhalants (N = 277)
Reason M SD
Curious about effects 2.76 1.07
Feeling bored 2.38 1.27
Easier to get than other drugs 2.25 1.41
Fun to use 2.03 1.33
To relax 1.89 1.28
Not dangerous 1.82 1.30
To forget about troubles 1.69 1.40
Peer pressure 1.60 1.37
Feeling sad 1.38 1.30
Feeling anxious 1.29 1.21
To impress others 1.26 1.23
Angry at someone 1.24 1.26
Family problems 1.23 1.29
Angry at self 1.10 1.17
Like more than other drugs 0.92 1.05
Table 2
Empirical fit of models and class sizes based on LPA
Class solution BIC Entropy Class size, n (%)
1 Class 13,861.47 NA 277 (100)
2 Classes 13,027.28 .925 169 (61.8)
108 (39.2)
3 Classes 12,766.44 .903 85 (30.6)
122 (44.1)
70 (25.3)
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3.4. Validation analysis
A validation of the three-class solution was conducted by
examining the associations among the three classes with
demographic and clinical variables. Chi-square tests
revealed that class composition did not differ by race,
v2(2) = 5.58, p = .06, gender, v2(2) = 2.32, p = .313, receipt
of public assistance, v2(2) = 1.74, p = .42, or urbanicity,
v2(6) = 5.85, p = .44. One-way analysis of variance
(ANOVA) showed that class composition was not associ-
ated with age, F(2) = 0.014, p = .99.
ANOVA with Dunnett’s T3 post hoc comparisons
revealed significant differences on all the clinical variables
(see Table 3). On the Substance Use Problems Index, all
three groups were significantly different. Classes 1 and 3
exhibited mean values that were different from Class 3 on
all clinical measures. The mean values of Classes 1 and 2
exhibited significant differences on just the Substance Use
Problems Index. Class 1 had the lowest mean values on all
the measures, and the abusing class had lower mean values
than the dependence class. The strongest effect sizes
observed, based on g2, were on the Substance Use Problems
Index (g2 = .13), Anxiety-BSI (g2 = .14), and the Global
Severity Index (g2 = .13).
Cohen (1988) suggested that a zero-order correlation of
.30 was a medium effect size. Thus, the proportion of
shared variance (r2) of this effect is .09. This provides the
basis for comparing the g2 values, suggesting that the
effect sizes in these analyses are of moderate strength and
of clinical significance.
The number of different types of inhalants used ranged
from 1 to 16. This was a count variable; hence, it exhibited
a high skew (M = 4.18, SD = 3.04, skew = 1.05). Thus,
it was dichotomized, reflecting one and more than one
type of inhalant used over the lifetime. The classes
showed significant differences on this measure, v2(2) =
10.6, p = .005, U = .21. Thirty-eight percent of Class 1
subjects used more than one type of inhalant over the
lifetime; among Class 2 subjects, 76%; and among Class
3 subjects, 86%.
Fig. 1. Three-class solution representing mean agreement on reasons for using inhalants.
Table 3
Tests of association among three-class solution and clinical variables using ANOVA (N = 277)
Variables Class 1, M (SD) Class 2, M (SD) Class 3, M (SD) F statistica,b,c p (g2)
Suicidality Index 2.86 (2.43) 2.98 (2.41) 4.27 (2.21) 8.42b,c b.001 (.06)
Substance Use Problems Index 4.14 (2.35) 5.31 (1.94) 6.24 (.159) 21.34a,b,c b.001 (.13)
Depression (BSI) 4.73 (5.27) 5.49 (4.70) 8.91 (6.38) 13.25b,c b.001 (.09)
Anxiety (BSI) 4.16 (4.39) 4.90 (4.18) 9.03 (6.30) 22.30b,c b.001 (.14)
Paranoid ideation (BSI) 6.36 (4.77) 6.59 (4.44) 9.29 (4.69) 9.64b,c b.001 (.07)
Psychoticism (BSI) 3.39 (3.69) 4.29 (4.07) 6.87 (5.04) 13.82b,c b.001 (.09)
Global Severity Index 42.98 (32.84) 48.52 (30.38) 76.71 (43.58) 20.54b,c b.001 (.13)
Externalizing behaviors 23.14 (16.05) 27.41 (19.50) 33.06 (19.67) 5.41b b.001 (.04)
Polysubstance use 34.02 (21.84) 36.16 (19.57) 42.67 (22.60) 3.46b .03 (.02)
Note. Dunnett’s post hoc comparisons conducted for all ANOVAs: a = Classes 1 and 2 are different; b = Classes 1 and 3 are different; c = Classes 2 and 3 are
different.
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4. Discussion
Before reviewing the main findings of this study, it is
important to recognize the study limitations. Most impor-
tant, these data are representative of only incarcerated
adolescents. As an enriched sample, these youth typically
have a considerable history of substance use and psychiatric
problems, which makes it difficult to determine the extent to
which the classes and their associations with clinical
variables are associated with use of inhalants. Additionally,
there are differential system responses to adolescent
offending behavior—that is, some enter the juvenile justice
system directly, whereas others may be diverted to
psychiatric systems of care or adjudicated directly back to
the community. Thus, the demographic and clinical charac-
teristics of this study sample may differ substantially from
adolescents drawn from community-based samples.
Although the reasons for using inhalants were adapted from
an existing measure (i.e., RFDQ), the psychometric proper-
ties of the measure in this study are not completely known.
Therefore, the results should be interpreted with caution.
Curiosity about the effects of inhalants, feelings of
boredom, and peer pressure were the major features of
Class 1. Members of this class also exhibited the lowest
mean value on the Substance Use Problems Index and had
a smaller proportion of class members using only one
type of inhalant compared to the other classes. Although
data on frequency of use were not available, these data
provide some evidence that members of Class 1 were
bexperimentalQ users.
Members of Class 2 showed consistently higher mean
values than members of Class 1 on all the reasons for use. A
distinguishing feature of Class 2 was that inhalants were
used because members considered them easier to get. The
higher mean values for all the reasons, access to inhalants,
and greater proportion of using multiple inhalants suggest
that these adolescents can be regarded as bactiveQ users.
Compared to Class 2, Class 3 exhibited similar pattern of
reasons for using with the exception of reasons related to
interpersonal problems and affective symptoms. Specifi-
cally, members of this class were using to forget about
troubles, to assuage feelings of sadness, to deal with family
problems, and because they felt angry with someone else.
These members were clearly using inhalants to cope with
various types of distress. The proportion of subjects in Class
3 using multiple inhalants was significantly higher than the
proportion of subjects in Classes 1 and 2. Thus, the
members of this class can be regarded as bcoping/high-
distressQ inhalant users. The consistent associations with
clinical variables also support this, with members of Class 3
exhibiting significantly greater severity scores than Class 1
on all these measures.
It should be noted that Class 1 members displayed the
lowest levels of clinical severity on all the measures in
relation to Class 3. However, there was very little
differentiation of Class 2 from Class 1. Specifically, only
one clinical variable, substance use severity, was associated
with a significant difference across these classes. Although
they exhibited unique reasons for use, a broader set of
clinical differences across the classes is needed to validate
this class structure. Moreover, the foregoing analysis of
class structure and associations with clinical variables does
not disentangle any particular causal mechanisms. While
the reasons for use studied may explain the differential
pattern of inhalant use and consequently manifest levels of
psychopathology, it is also possible that the psychopathol-
ogy and history of the individual influence the expressed
reasons for use. It is also possible that there is a complex
feedback relationship at play.
Longitudinal data, which were not available for this
study, would be especially useful to reveal whether classes
differed in their use of inhalants over time. A longitudinal
analysis can also help reveal whether adolescent inhalant
users move in a stage-wise process from experimentation
to a substance use disorder. Future taxonomic research on
inhalant users should attempt to study the stability of
identified classes across time, employ diagnostic mental
health inventories, and assess the moderating effects of
situational influences, family problems, and inhalant use
and other drug use progression. Future research should
also attempt to integrate reasons for using with desistance
from inhalants and other drugs (e.g., Titus, Godley, &
White, 2006).
Findings reveal that curiosity about inhalant use is high
in both the univariate summary and LPA. This finding may
possess clear service implications with respect to preventa-
tive efforts (e.g., social marketing). It may also be possible
to develop targeted treatment approaches, such as using the
expressed reasons as a guide in cognitive–behavioral or
motivational interviewing. For example, members of the
abusers/high-distress class (Class 3) reported using inhalants
to cope with a variety of problems. Treatment professionals
could guide these individuals in systematically assessing the
effectiveness and consequences of such behaviors and
explore other alternatives.
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